Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 24, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Overactive Bladder SyndromeOveractive Bladder (OAB)Transcutaneous Posterior Tibial Nerve Stimulation (TTNS)
Interventions
DEVICE

Efficacy of remotely monitored transcutaneous posterior tibial nerve neuromodulation via a test device at 12 week and 12 month

"T-PTNS treatment will be performed at home with an external generator and two surface electrodes SmartUric medical device. Each T-PTNS session will consist of test and treatment sections. The treatment will be planned and carried out by researchers.~The treatment dose is 1 day/week, 30 minutes/session, totaling 12 sessions. Treatment Pulse Frequency: 20 Hz, Treatment Pulse Width: 200us (microsecond)."

DEVICE

Efficacy of remotely monitored transcutaneous posterior tibial nerve neuromodulation via a placebo device at 12 week

These are devices that have the same physical appearance, interface and feedback features, but are prepared in a way that they will not provide electrical stimulation during the treatment session. They are delivered to the Contract Research Organization (CRO) by the project manager and are randomized through the CRO and given to the researchers with a code. The duration and frequency of treatment will be the same as the treatment group.

Trial Locations (1)

35100

RECRUITING

EGE UNIVERSITY, FACULTY OF MEDICINE, Department of Obstetrics and Gynecology, Izmir

All Listed Sponsors
collaborator

Health Institutes of Turkey

OTHER_GOV

lead

Ege University

OTHER